Pharmaceutical Companies Performance Tables 2006 Who are the winners and losers in the global pharmaceutical industry?This essential fully updated ...more

Market Briefing November 2006

World Generic Market Report 2007 The changing face of the generics industryThe pace of corporate consolidation grows ever faster. ...more

Management Report November 2006

Injectable Generic Drugs: Prospects and Opportunities to 2010 A number of high value drugs due to come off patent in the USA and Europe over the next few years are ...more

Market Study October 2006

In Vitro Diagnostic Companies Analysis This new report from Espicom provides an evaluation of the products, alliances and performance of over 30 ...more

Market Briefing October 2006

Emerging Opportunities in Cancer Nanomedicine Providing… A review of nanomedicine and its role in the anticancer market An assessment of the main ...more

Management Report August 2006

Asthma and COPD Drug Discoveries: what the future holds A fast growing sector with strong products and players - but what will the COPD/Asthma landscape look ...more

Market Study August 2006

Inflammatory Bowel Disease: what the future holds Providing....- Unique sales forecasts by product to 2010- Critical assessment and estimates, where ...more

Market Study August 2006

What's Hot in Cancer Drug R&D? Research and Development in Cancer continues to generate enormous interest within industry and commerce. ...more

Market Briefing July 2006

The Future of Monoclonal Antibodies Therapeutics: Innovation in antibody engineering, key growth strategies and forecasts to 2011 The monoclonal antibody (mAb) market has grown rapidly in recent years, reaching sales of $14bn in 2005, ...more

Management Report July 2006

Cardiovascular Drug Discoveries This market analysis provides a comprehensive examination of key cardiovascular therapy areas: ...more

Market Study May 2006

New Drug Futures: Respiratory Chapter ASTHMAAsthma affects over 100 million people worldwide. ...more

Management Report May 2006

New Drug Futures: Musculoskeletal Chapter ANTI-RHEUMATOID DRUG SALESWe estimate the rheumatoid arthritis (RA) market was worth around US$5. ...more

Management Report May 2006

New Drug Futures: Cancer Chapter Cancer is the second most common cause of mortality in the developed world and accounts for around 12. ...more

Management Report May 2006

New Drug Futures: Vaccines Chapter ROTAVIRUSIt is estimated that all children over five years old are infected with rotavirus, however the ...more

Management Report May 2006

New Drug Futures: Anti-Infective Chapter ANTIBIOTIC SALESWe estimate the antibiotic market is currently worth nearly US$31 billion, equivalent to ...more

Management Report May 2006

New Drug Futures: Central Nervous System Chapter CNS disorders represent more than 15% of the global cost of disease. ...more

Management Report May 2006